Dry age-related macular degeneration (AMD) has long been associated with limited treatment options. Today, however, new research and therapies are transforming how the condition is managed, offering patients more ways to slow progression and protect their vision.
New Treatments Targeting Dry AMD Progression
One of the most important developments is the introduction of treatments that address the underlying disease process. Complement inhibitor therapies, used in advanced stages such as geographic atrophy, are designed to slow retinal cell damage and reduce the rate of vision loss. While not a cure, they mark a major step forward in dry AMD care.
Photobiomodulation (Light Therapy) for Dry AMD
Photobiomodulation, also known as light therapy, is a non-invasive treatment that uses specific wavelengths of light to support retinal cell function. By improving cellular energy production and reducing inflammation, it may help slow progression and maintain visual function over time.
Future Innovations in Dry AMD Treatment
Ongoing research is exploring exciting new possibilities, including gene therapy and stem cell treatments aimed at repairing or replacing damaged retinal cells. While still in development, these approaches represent the future of dry AMD treatment and the potential for more transformative outcomes.
With continued advancements and a personalised approach to care, patients with dry AMD now have more options than ever. Early diagnosis, regular monitoring, and access to emerging treatments are key to preserving vision and maintaining quality of life.